Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD

研究 C9orf72 在 ALS/FTD 自噬和代谢失调中的作用

基本信息

  • 批准号:
    9904831
  • 负责人:
  • 金额:
    $ 56.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-05-15 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

Neurodegeneration is an increasing public health issue and remains an unsolved biomedical challenge. Genetic discoveries have provided news avenues for investigating the molecular mechanisms of several neurodegenerative diseases. Recently, a hexanucleotide repeat expansion in a noncoding region of the C9orf72 gene was linked to the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). ALS is characterized by loss of motor neurons, and the C9orf72 mutation represents the most common genetic cause of both familial and sporadic ALS. FTD is characterized by degeneration of the frontal and temporal lobes of the brain and is the second most common type of dementia for people older than 65; the C9orf72 mutation is also the most common genetic causes for FTD. The C9orf72 mutation is also found to contribute to Alzheimer’s disease and Huntington’s disease. Despite intense efforts and rapid advances, our understanding of the disease mechanisms and treatment strategies for C9orf72-linked ALS/FTD are still at the early stages. To help relieve the public health burden associated with these diseases, it is important to understand the mechanisms underlying the pathogenesis. We have recently discovered that C9orf72 plays an important role in the regulation of autophagy and related metabolic processes, suggesting that further studies of C9orf72 functions could shed light on the mechanism of ALS/FTD pathogenesis. The goal of the proposed project is to elucidate the mechanisms through which dysregulation of C9orf72 functions leads to molecular defects and neuronal toxicity. The specific aims are to identify the central mechanisms through which C9orf72 regulates autophagy and related metabolism, to delineate the pathways through which the pathogenesis is generated, and to identify potential intervention strategies. The proposed studies, which combine biochemical, molecular, and genetic approaches, are expected to provide insight into fundamental mechanisms of neurodegeneration in ALS/FTD that may ultimately leads to novel approaches for treating these devastating neurodegenerative diseases.
神经退行性变是一个日益严重的公共卫生问题, 生物医学挑战遗传学的发现为研究人类基因组提供了新的途径。 几种神经退行性疾病的分子机制最近,一种六核苷酸 在C9 orf 72基因的非编码区的重复扩增被链接到 神经退行性疾病肌萎缩侧索硬化症(ALS)和额颞叶痴呆 (FTD)。ALS的特征在于运动神经元的丧失,并且C9 orf 72突变代表了ALS的特征。 是家族性和散发性肌萎缩侧索硬化症最常见的遗传原因。FTD的特征在于 大脑额叶和颞叶的退化,是第二常见的 一种65岁以上的痴呆症; C9 orf 72突变也是最常见的 FTD的遗传原因。C9 orf 72突变也被发现有助于阿尔茨海默病 和亨廷顿舞蹈症。尽管作出了巨大努力并取得了迅速进展,但我们对 C9 orf 72连锁ALS/FTD的疾病机制和治疗策略仍处于早期阶段, 阶段为了帮助减轻与这些疾病相关的公共卫生负担, 以了解发病机制。我们最近发现, C9 orf 72在自噬和相关代谢过程的调节中起重要作用, 这表明对C9 orf 72功能的进一步研究可以阐明 ALS/FTD发病机制。该项目的目标是阐明 C9 orf 72功能失调导致分子缺陷, 毒性具体的目的是确定C9 orf 72 调节自噬和相关的代谢,以描绘通过哪些途径, 发病机制的产生,并确定潜在的干预策略。拟议 结合了生物化学、分子生物学和遗传学方法的联合收割机研究, 深入了解ALS/FTD中神经变性的基本机制, 最终导致治疗这些破坏性神经退行性疾病的新方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jiou Wang其他文献

Jiou Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jiou Wang', 18)}}的其他基金

Molecular Basis of Pathogenic Cascades in ALS/FTD Initiated from C9orf72 Hexanucleotide Repeat Expansion
C9orf72 六核苷酸重复扩增引发 ALS/FTD 致病级联的分子基础
  • 批准号:
    10512236
  • 财政年份:
    2022
  • 资助金额:
    $ 56.75万
  • 项目类别:
Molecular Basis of Pathogenic Cascades in ALS/FTD Initiated from C9orf72 Hexanucleotide Repeat Expansion
C9orf72 六核苷酸重复扩增引发 ALS/FTD 致病级联的分子基础
  • 批准号:
    10659232
  • 财政年份:
    2022
  • 资助金额:
    $ 56.75万
  • 项目类别:
Mechanisms of RNA and Protein Dysregulations in ALS/FTD Associated with FUS and Ubiquilin 2
与 FUS 和泛素 2 相关的 ALS/FTD 中 RNA 和蛋白质失调的机制
  • 批准号:
    10530653
  • 财政年份:
    2019
  • 资助金额:
    $ 56.75万
  • 项目类别:
Mechanisms of RNA and Protein Dysregulations in ALS/FTD Associated with FUS and Ubiquilin 2
与 FUS 和泛素 2 相关的 ALS/FTD 中 RNA 和蛋白质失调的机制
  • 批准号:
    10401555
  • 财政年份:
    2019
  • 资助金额:
    $ 56.75万
  • 项目类别:
Mechanisms of RNA and Protein Dysregulations in ALS/FTD Associated with FUS and Ubiquilin 2
与 FUS 和泛素 2 相关的 ALS/FTD 中 RNA 和蛋白质失调的机制
  • 批准号:
    10318610
  • 财政年份:
    2019
  • 资助金额:
    $ 56.75万
  • 项目类别:
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
研究 C9orf72 在 ALS/FTD 自噬和代谢失调中的作用
  • 批准号:
    10400837
  • 财政年份:
    2015
  • 资助金额:
    $ 56.75万
  • 项目类别:
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
研究 C9orf72 在 ALS/FTD 自噬和代谢失调中的作用
  • 批准号:
    10606605
  • 财政年份:
    2015
  • 资助金额:
    $ 56.75万
  • 项目类别:
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
研究 C9orf72 在 ALS/FTD 自噬和代谢失调中的作用
  • 批准号:
    10133157
  • 财政年份:
    2015
  • 资助金额:
    $ 56.75万
  • 项目类别:
Investigating disease Mechanisms in C9orf72-linked ALS/FTD
研究 C9orf72 相关 ALS/FTD 的疾病机制
  • 批准号:
    9066822
  • 财政年份:
    2015
  • 资助金额:
    $ 56.75万
  • 项目类别:
Neurodegeneration and Proteotoxicity Dissected in C. elegans and Mammals
线虫和哺乳动物的神经变性和蛋白质毒性剖析
  • 批准号:
    9281039
  • 财政年份:
    2011
  • 资助金额:
    $ 56.75万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
  • 批准号:
    498278
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
  • 批准号:
    24K04938
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了